Description

Details of equity shares listing with lock-in periods and distinctive number ranges for NEPHROCARE HEALTH SERVICES LIMITED.

Summary

BSE has listed equity shares of NEPHROCARE HEALTH SERVICES LIMITED with a total of 10,03,40,717 shares across multiple categories. The listing includes shares under various lock-in periods ranging from 1 month to 18 months, as well as shares not under lock-in for IPO public, ESOP, and AIF Category II investors.

Key Points

  • Total equity shares listed: 10,03,40,717
  • Distinctive numbers range: 1 to 10,03,40,717
  • Multiple lock-in categories with varying periods
  • Mix of demat and physical shares (minimal physical: 77,640 shares)
  • Lock-in periods: 1 month, 3 months, 6 months, and 18 months
  • Shares exempt from lock-in: IPO Public (1,32,85,101 shares), ESOP (28,28,960 shares), and AIF Category II (28,28,959 shares)

Lock-in Details

18-Month Lock-in (15-Dec-2025 to 16-Jun-2027):

  • 7,655 demat shares (Distinctive Nos. 1 to 7,655)
  • 2,44,36,154 demat shares (Distinctive Nos. 85,296 to 2,45,21,449)

6-Month Lock-in (15-Dec-2025 to 16-Jun-2026):

  • 77,640 physical shares (Distinctive Nos. 7,656 to 85,295)
  • 5,13,48,216 demat shares (Distinctive Nos. 2,45,21,450 to 7,58,69,665)

3-Month Lock-in (15-Dec-2025 to 14-Mar-2026):

  • 17,67,810 demat shares (Distinctive Nos. 7,96,29,888 to 8,13,97,697)

1-Month Lock-in (07-Jul-2025 to 08-Jan-2026):

  • 18,82,080 demat shares (Distinctive Nos. 7,58,69,666 to 7,77,51,745)

Not Under Lock-in:

  • AIF Category II: 28,28,959 demat shares (Distinctive Nos. 8,13,97,698 to 8,42,26,656)
  • ESOP: 28,28,960 demat shares (Distinctive Nos. 8,42,26,657 to 8,70,55,616)
  • IPO Public: 1,32,85,101 demat shares (Distinctive Nos. 8,70,55,617 to 10,03,40,717)

Compliance Requirements

  • Lock-in restrictions must be observed for applicable share categories
  • Shares under lock-in cannot be traded until respective lock-in expiry dates
  • Physical shares (77,640) maintained for distinctive numbers 7,656 to 85,295
  • Demat form mandatory for majority of shares

Important Dates

  • 07-Jul-2025: Start of 1-month lock-in period
  • 08-Jan-2026: Expiry of 1-month lock-in period
  • 15-Dec-2025: Start of multiple lock-in periods (1, 3, 6, and 18 months)
  • 14-Mar-2026: Expiry of 3-month lock-in period
  • 16-Jun-2026: Expiry of 6-month lock-in periods
  • 16-Jun-2027: Expiry of 18-month lock-in periods

Impact Assessment

Market Liquidity: Only 13.23% of total shares (1,32,85,101 IPO public shares) are immediately available for trading without lock-in restrictions. Additional shares will gradually become tradable as lock-in periods expire.

Trading Volume: Expect limited initial trading volumes until lock-in periods expire progressively between January 2026 and June 2027.

Investor Categories: Institutional investors (AIF Category II), employees (ESOP holders), and retail/public investors have different lock-in treatments, affecting supply dynamics in secondary market.

Impact Justification

New equity listing with multiple lock-in categories affecting trading and liquidity for institutional and retail investors